MAC
53
5
SPG
45
2
HP
44
14
ICE
53
5
KR
50
5
FOXA
67
5
HST
53
4
SLG
37
6
MDLZ
28
2
ORLY
48
3
BXP
39
5
JCI
44
7
KHC
11
2
MMC
46
5
MSI
52
3
MHK
25
5
EOG
28
2
KSS
36
2
RF
44
10
LEG
16
2
MAC
53
5
SPG
45
2
HP
44
14
ICE
53
5
KR
50
5
FOXA
67
5
HST
53
4
SLG
37
6
MDLZ
28
2
ORLY
48
3
BXP
39
5
JCI
44
7
KHC
11
2
MMC
46
5
MSI
52
3
MHK
25
5
EOG
28
2
KSS
36
2
RF
44
10
LEG
16
2
Financhill
Back

Genmab AS Stock Predictions

FREE REPORT: 2025 Gold Price Outlook

Get Your Copy of "2025 Gold Forecast: A Perfect Storm for Demand" Here.
Sell
28

GNMSF
Genmab AS

Last Price:
$213.00
Seasonality Move:
-1.52%

7 Day Trial

ALL ACCESS PASS

$ 7

This Tech Company Grew 32,481%...

This is a paid advertisement for Mode Mobile Regulation A offering. Please read the offering circular and related risks at invest.modemobile.com.

Genmab AS Stock Forecast

  • Over the next 52 weeks, Genmab AS has on average historically risen by 0.3% based on the past 9 years of stock performance.
  • Genmab AS has risen higher in 3 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%
  • Is Genmab AS Stock Undervalued?
    The current Genmab AS [GNMSF] share price is $209.50. The Score for GNMSF is 28, which is 44% below its historic median score of 50, and infers higher risk than normal.
  • GNMSF is currently trading in the 20-30% percentile range relative to its historical Stock Score levels.

Will Genmab AS Stock Go Up Next Year?

  • Over the next 52 weeks, Genmab AS has on average historically risen by 0.3% based on the past 9 years of stock performance.

Genmab AS Stock Rating

Sell
28
Genmab AS (GNMSF) is a Sell

Is Genmab AS overpriced?

  • Genmab AS has risen higher in 3 of those 9 years over the subsequent 52-week period, corresponding to a historical accuracy of 33.33%

Genmab AS Stock Price History

Is GNMSF stock going to rise?

  • The current trend is relatively stagnant and GNMSF is experiencing buying pressure, which is a positive indicator for future bullish movement.

Stock Information

Stock Info

Exchange:
OTCM
Country:
Denmark
Industry:
Biotechnology
Sector:
Health Care
Type:
stock
Website:
genmab.com

52-Week Data

52-Week High:
334.33
52-Week Low:
192.20

Prediction Charts

Market Cap:
13.3B
Price in USD:
209.50
Volume:
1.6K
Beta:
0.64

Technical Analysis

SMA50:
217.96
SMA100:
238.88
SMA200:
259.62
52-Wk Change:
-32.47%

Stock Predictions

  • Is Genmab AS stock public?
    Yes, Genmab AS is a publicly traded company.
  • What is the Genmab AS stock quote today?
    The Genmab AS stock price is 209.50 USD today.
  • How to buy Genmab AS stock online?
    You can buy Genmab AS shares by opening an account at a top tier brokerage firm, such as TD Ameritrade or tastyworks.

14-Day Historical Data

Date Opening Closing Minimum Maximum
Dec-3 221.20 213.46 221.20 210.95
Dec-4 212.20 209.25 224.00 209.25
Dec-5 224.36 227.35 227.35 212.40
Dec-6 220.10 212.50 224.50 212.50
Dec-9 223.00 216.80 224.80 216.80
Dec-10 218.00 224.00 224.00 214.20
Dec-11 212.96 212.80 221.20 210.00
Dec-12 206.00 205.25 213.95 202.85
Dec-13 207.20 201.00 211.60 201.00
Dec-16 206.40 204.37 208.50 196.89
Dec-17 195.02 198.00 205.24 192.20
Dec-18 207.76 203.33 210.01 203.32
Dec-19 208.02 207.35 209.18 196.50
Dec-20 206.64 209.50 209.50 198.00

Genmab AS Earnings

Genmab AS Earnings Report: Per Share Genmab AS Earnings Q1 Q2 Q3 and Q4 last year and next year.

Genmab AS Forecast Revenue Growth

Genmab AS Stock Analysis: Historical quarterly revenues per share for Genmab AS and historical quarterly revenue growth:

* Genmab AS stock forecasts short-term for next days and weeks may differ from long term prediction for next month and year based on timeline differences.